Transcept finally gets FDA nod on Intermezzo
(Reuters) – Transcept Pharmaceuticals Inc said the U.S. health regulator has approved its sleep drug Intermezzo as a first-of-its kind treatment of a particular type of insomnia.
Transcept finally gets FDA nod on Intermezzo
November 24, 2011 By